Study of Recombinant Human-Mouse Chimeric Anti-CD20 Monoclonal Antibody to Treat Non-hodgkin's Lymphoma

Clinical trial NCT01459887 · COMPLETED

Trial details

NCT number: NCT01459887
Sponsor: Shanghai CP Guojian Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diffuse Large B Cell Lymphoma

Start date: 2006-09-01
Primary completion: 2010-12-01
Enrollment: 278

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.